Effects of SGLT2 Inhibitors in the Treatment of a Population With Type 2 Diabetes Mellitus

Endocrine Abstracts
doi 10.1530/endoabs.41.ep556
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

SGLT2 Inhibitors: The Future for Treatment of Type 2 Diabetes Mellitus and Other Chronic Diseases

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Associated Antidiabetic Treatment in a Rural Population With Type 2 Diabetes Mellitus

Endocrine Abstracts
2016English

Discovery of Natural SGLT2-Inhibitors for Type 2 Diabetes – Possible Way to Reduce Side Effects

Journal of Natural Remedies
Pharmacology
2016English

Effective SGLT2 Inhibitor for Patient With Type 2 Diabetes Mellitus (T2DM) and Depression

2020English

Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus

Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
2016English

The Potential Role of Sodium Glucose Co-Transporter 2 Inhibitors in the Early Treatment of Type 2 Diabetes Mellitus

International Journal of Clinical Practice
Medicine
2015English

How Representative Are the Patients Included in the CV Outcome Trials With SGLT2 Inhibitors of a General Type 2 Diabetes Population? A Large European Observational Study

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Pharmacologic Treatment Strategies in Children With Type 2 Diabetes Mellitus

Clinical Pediatric Endocrinology
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2013English

Dapagliflozin: A New Adjunct in the Treatment of Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy